Chugai Pharmaceutical Co. Ltd. reported unaudited consolidated earnings results for the fourth quarter and year ended December 31, 2015. For the quarter, the company reported revenues were JPY 131.1 billion compared to JPY 127.7 billion a year ago. Operating profit was JPY 19.7 billion compared to JPY 16.7 billion a year ago. Profit before taxes was JPY 19.9 billion compared to JPY 16.7 billion a year ago. Net income attributable to the company shareholders was JPY 13.5 billion compared to JPY 11.3 billion a year ago. Diluted earnings per share were JPY 24.65 compared to JPY 20.60 a year ago. Core revenues were JPY 131.1 billion compared to JPY 127.7 billion a year ago. Core operating profit JPY 20.4 billion compared to JPY 17.2 billion a year ago. Core profit before taxes was JPY 20.5 billion compared to JPY 17.3 billion a year ago. Core net income attributable to the company shareholders was JPY 13.9 billion compared to JPY 11.6 billion a year ago. Core diluted earnings per share were JPY 25.42 compared to JPY 21.19 a year ago.

For the period, the company's revenues were JPY 498,839 million compared to JPY 461,109 million a year ago. Operating profit was JPY 86,784 million compared to JPY 75,859 million a year ago. Profit before taxes was JPY 87,276 million compared to JPY 76,164 million a year ago. Net income attributable to the company shareholders was JPY 61,125 million compared to JPY 50,980 million a year ago. Diluted earnings per share were JPY 111.79 compared to JPY 93.38 a year ago. Total cash flows from operating activities were JPY 62,918 million compared to JPY 37,034 million a year ago. Purchase of property, plant and equipment was JPY 18,367 million compared to JPY 16,232 million a year ago. Purchase of intangible assets was JPY 6,472 million compared to JPY 2,935 million a year ago. Core revenues were JPY 498.8 billion compared to JPY 461.1 billion a year ago. Core operating profit JPY 90.7 billion compared to JPY 77.3 billion a year ago. Core net income was JPY 64.9 billion compared to JPY 53.0 billion a year ago.

For the year ending December 31, 2016, the company expects revenues of JPY 495,000 million, core operating profit of JPY 71,000 million, core earnings per share of JPY 92.54.